Capital International Investors
Position in TERN — Terns Pharmaceuticals, Inc.
CIK 1562230
Los Angeles, CA
Position in TERN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,424,504
+34.4% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International Investors holds $7,948,137,729 across 16 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,695,144 | $2,332,218,879 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,273,770 | $1,977,800,283 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,210,221 | $1,199,786,678 | |
| 4 | INSM |
INSMED Inc
|
8,238,124 | $878,348,780 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,988,614 | $530,403,126 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,361,639 | $142,548,530 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
2,963,410 | $139,398,806 | |
| 8 | COAG |
Hemab Therapeutics Holdings, Inc.
|
3,603,876 | $132,370,365 |
All Filings in TERN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 1,424,504 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | — | 1,060,000 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||